Industry Should Work With NIH To Inform Public About "Where Drugs Come From," Lilly Exec Says
This article was originally published in The Pink Sheet Daily
Executive Summary
In the face of increasing pressures on drug prices, Lilly sees benefit in working with government to "get the word out" about how drugs are developed.